Trial Profile
Multicentral phase II study of adjuvant UFT/LV chemotherapy with completely resected rectal cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Tegafur/uracil/folinic acid (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 11 Nov 2013 New trial record